We’re excited to welcome Jens Bjørheim to the NaDeNo team as our Chief Medical Officer.

Jens brings a wealth of experience in clinical development and biotech leadership, and he will play a pivotal role in advancing our lead candidate from preclinical promise to patient impact. As CMO, he will lead our clinical strategy and trial design, while also identifying new opportunities to apply our nanoparticle drug delivery platform to areas of high unmet medical need.

His impressive track record includes senior roles at AstraZeneca, Novartis, BASF (Pronova), Ultimovacs, and others, where he was instrumental in advancing innovative therapies and contributing to two successful public listings.

Jens shares our deep commitment to improving patient outcomes and further strengthening our technology platform.